Position in AVIR
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$9,463,642
+$948,087 QoQ
Shares Held
2,035,192
+28.6% QoQ
Ownership
2.54%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#7
of 124 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AVIR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026ACADIAN ASSET MANAGEMENT LLC holds $731,256,203 across 167 Biotechnology names. AVIR ranks #17 (1.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INCY |
Incyte Corp
|
1,664,999 | $188,744,286 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
157,440 | $98,170,137 | |
| 3 | IMCR |
Immunocore Holdings plc
|
1,209,894 | $38,414,134 | |
| 4 | RIGL |
Rigel Pharmaceuticals Inc
|
591,686 | $23,146,756 | |
| 5 | EXEL |
Exelixis, Inc.
|
421,444 | $22,930,768 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
42,122 | $20,923,261 | |
| 7 | TBPH |
Theravance Biopharma, Inc.
|
1,174,910 | $19,973,470 | |
| 8 | PRTA |
Prothena Corp Public Ltd Co
|
2,010,645 | $19,684,214 |
All Filings in AVIR
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9,463,642 | 2,035,192 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $8,515,555 | 1,582,817 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $4,654,937 | 1,303,904 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $2,812,341 | 969,773 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $3,304,245 | 917,846 | Shares | Defined | 2025-08-07 | |
| 2025-03-31 | $2,744,359 | 917,846 | Shares | Defined | 2025-05-21 | |
| 2024-12-31 | $3,125,298 | 932,925 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $3,125,298 | 932,925 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $3,093,211 | 934,505 | Shares | Defined | 2024-08-06 | |
| 2024-03-31 | $3,888,330 | 962,458 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $2,935,496 | 962,458 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $2,963,748 | 987,916 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $3,726,068 | 996,275 | Shares | Defined | 2023-08-07 | |
| 2023-03-31 | $3,720,895 | 1,110,715 | Shares | Defined | 2023-05-11 | |
| 2022-12-31 | $4,176,282 | 868,250 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $4,698,591 | 825,763 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $5,072,396 | 714,422 | Shares | Defined | 2022-08-09 | |
| 2022-03-31 | $6,155,598 | 852,576 | Shares | Defined | 2022-05-12 | |
| 2021-12-31 | $2,434,013 | 272,261 | Shares | Defined | 2022-02-10 | |
| 2021-09-30 | $1,063,895 | 30,345 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $724,176 | 33,714 | Shares | Defined | 2021-08-11 | |
| No filing history on record for this holder in this stock. | ||||||